Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Contact information


elizabeth.dellar@ndcn.ox.ac.uk

Social media

Elizabeth Dellar

DPhil MBiolSci

Postdoctoral Researcher

Biography

I graduated with an MBiolSci in Molecular Biology from the University of Sheffield, during which I worked on several neurodegenerative diseases, firstly at Sheffield Institute for Translational Neuroscience (SITraN), and then in industry at Eli Lilly in Surrey.  In 2016 I joined the Oxford Interdisciplinary Bioscience Programme, where my DPhil research used Drosophila as a model system to investigate RNA cargo packaging into extracellular vesicles (EVs) under normal and oxidative stress conditions.

Research Summary


My research is centred on biomarker discovery for the neurodegenerative disease amyotrophic lateral sclerosis (ALS). This involves proteomic profiling of cerebrospinal fluid from patients and asymptomatic carriers of disease-causing C9orf72 variant in ALS. I have a particular  focus on extracellular vesicles (EVs), derived from biofluids,  induced pluripotent stem cells and post mortem tissue, as a source of potential new biomarkers in neurodegenerative diseases.

Key publications